))
70: New treatments for Alzheimer’s Disease: Hopes and Controversies
Manage episode 428082163 series 3559008
Inhoud geleverd door University of Iowa Carver College of Medicine - Division of Continuing Medical Education and University of Iowa Carver College of Medicine Continuing Medical Education. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door University of Iowa Carver College of Medicine - Division of Continuing Medical Education and University of Iowa Carver College of Medicine Continuing Medical Education of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Join Dr. Szot, Dr. Larson, Dr. Shim, and Dr. Reist as they discuss new therapeutic agents for the treatment of Alzheimer’s disease and their role in management of the disease.
CME Credit Available: https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=66930
Resources:
Lecanemab in Early Alzheimer’s Disease. New England Journal of Medicine. DOI: 10.1056/NEJMoa2212948. PMID: 36449413
Lecanemab: Looking Before We Leap. Neurology. DOI: 10.1212/WNL.0000000000207505. PMID: 37479527
Host: Joseph Szot, MD Associate Dean for Continuing and Integrated Medical Education Clinical Professor of Internal Medicine University of Iowa Carver College of Medicine
Guests: Scott Larson, MD Clinical Assistant Professor of Family Medicine University of Iowa Department of Family Medicine
Jeff Reist, PharmD Clinical Associate Professor of Pharmacy Practice and Science Director, Pharmacy Practice Learning Center University of Iowa College of Pharmacy
HyungSub Shim, MD of Neurology and Psychiatry Clinical Assistant Professor Medical Director of the Memory Disorders Clinic University of Iowa Department of Neurology and Psychiatry
Financial Disclosures: Dr. Joseph Szot, his guests and the members of the planning committee for Rounding@IOWA have no relevant financial relationships to disclose.
CME Credit Designation: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 0.5 ANCC contact hour.
Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)
75 afleveringen
Delen
